What the buyer is buying
by RFPFinder from the notice and attachments; the solicitation governsIntegral Care seeks a clinical laboratory service provider to deliver comprehensive laboratory testing and on-site specimen collection for behavioral health and community-based services. Proposals are evaluated by best value tradeoff via email submission by August 7, 2026.
Scope
- Comprehensive clinical laboratory testing and specimen collection services
- Support for diagnostic evaluation, medication management, metabolic monitoring, and clinical decision-making
How to get the bid documents
- Download the 2 documents below (no portal account needed)
- Check the submission requirements in the compliance checklist
- Submit by email before 5:00 PM CT on Oct 16
Details
- Place of performance
- Texas
- Buyer type
- Public
- Notice type
- RFP
- Solicitation no.
- IC-RFP-2026-003
- Category
- Supplies & Equipment · beta
- Estimated value
- $100K from notice
- Local presence
- Not required
- Amendments
- None since Jul 17
- Contact
- Christina Lundy
- Phone
- (737) 424-4349
Not stated in the notice: contract type, period of performance. Check the bid documents.
Contact details from the source notice. Contact the buyer only about this solicitation, and note the question deadline has passed.
Key dates
Change log
verified Sun, Oct 11 · 7:20 AM CTNo amendments since posting on Fri, Jul 17; verified Sun, Oct 11 · 7:20 AM CT.
Report a problem
Notice as published
Comprehensive Clinical Laboratory Testing and On-Site Specimen Collection Services
Integral Care is seeking proposals from qualified clinical laboratory service providers to deliver comprehensive laboratory testing and on-site specimen collection services supporting individuals receiving behavioral health and related community-based services.
The selected provider will furnish timely and reliable routine, specialized, and expedited laboratory services to support diagnostic evaluation, medication management, metabolic monitoring, crisis stabilization, substance use treatment, and ongoing clinical decision-making. Anticipated services include blood panels, hematology, endocrine testing, urinalysis, toxicology and drug screening, therapeutic drug monitoring, infectious disease testing, STI screening, HIV and hepatitis screening, tuberculosis testing, and other medically necessary clinical laboratory diagnostics.
Proposers should demonstrate the operational capacity to support high-volume testing, including CBC, A1C, lipid panels, comprehensive metabolic panels, thyroid testing, therapeutic drug monitoring, urine toxicology, and infectious disease screening. Proposers must also describe available STAT, rapid, or other expedited testing options and applicable turnaround times.
Questions Due: Monday, July 27, 2026.
Proposal Deadline: Friday, August 7, 2026, at 5:00 p.m. Central Daylight Time
Responses submitted by email to: [email on the source notice] Posting requirement: 21+ Days for Solicitation Notice
NIGP codes: 94855 Medical And Laboratory Services (Non
Listing collected from Texas Comptroller - Electronic State Business Daily (ESBD) + Centralized Master Bidders List (CMBL). Always confirm requirements in the original solicitation before you bid.